Surgical products maker G Surgiwear plans to raise Rs 740 crore via IPO, files draft document with SEBI

G Surgiwear IPO News

• G Surgiwear IPO | The company may consider raising funds up to Rs 74 crore in pre-IPO round i.e. before the filing of Red Herring Prospectus with the Registrar of Companies, which is a part of fresh issue component.

Did our AI summary help?

Uttar Pradesh-based surgical products maker G Surgiwear has tapped capital markets this week by filing draft document with the SEBI to raise funds up to Rs 740 crore via Initial Public Offering (IPO).

As a part of IPO, the company planned for issuance of fresh shares worth up to Rs 370 crore, and promoter Ghanshyam Das Agarwal will be selling same amount of shares via offer-for-sale.

Further, it may consider raising funds up to Rs 74 crore in pre-IPO round i.e. before the filing of Red Herring Prospectus with the Registrar of Companies, which is a part of fresh issue component.

G Surgiwear, founded by Ghanshyam Das Agarwal in 1990, has diversified its product portfolio beyond disposable surgical drapes and dressings and hydrocephalus shunt systems to include other surgical and medical implantable devices and products such as bone grafting products, lumbar external drainage systems and cerebral catheter reservoirs.

Click Here To Read All IPO News

Its manufacturing facility in Shahjahanpur, Uttar Pradesh has been accredited with international quality certifications, including a certificate of compliance with the requirements of World Health Organization - Good Manufacturing Practices (WHOGMP).

The company that also manufactures several products falling under stricter regulatory classifications (Class C and Class D) of the Central Drugs Standard Control Organization will spend Rs 167.2 crore of fresh issue proceeds for purchase of machinery, Rs 93.6 crore for repaying debt, and the remaining amount for general corporate purposes.

As of November 2025, its total outstanding borrowings amounted to Rs 140.1 crore.

G Surgiwear that competes with listed peer Poly Medicure has registered profit of Rs 58 crore for the financial year ended March 2025, rising 157.6 percent compared to Rs 22.5 crore in previous year. Revenue during the same period increased 32.7 percent to Rs 224 crore, up from Rs 168.7 crore.

In three months period ended June 2025, it has recorded profit of Rs 5.6 crore on revenue of Rs 44.6 crore.

Motilal Oswal Investment Advisors, and Nuvama Wealth Management are appointed as the book running lead managers for the G Surgiwear IPO.